Middle Molecule Find

Rulebook › V-tags › V355

V355 Fever, chills and other symptoms

Written V0355 on the CMS-2567 and in QCOR.

Enforces ANSI/AAMI RD47:2002/A1:2003, adopted by reference at 42 CFR 494.50(b)(1) · Appendix H Rev. 246, page 174 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

ANSI/AAMI RD47:2002/A1:2003 Requirements as Adopted by Reference 42 CFR 494.50(b)(1)

13.2 Symptoms

13.2.1 Fever and chills

Patients’ temperatures should be measured and recorded at least before and after dialysis with new and reprocessed dialyzers. A temperature of over 37.8° C or 100° F, taken orally, or chills should be reported to the physician, [advanced practice registered nurse or physician assistant]. Any patient with an unexplained fever and/or chills should be evaluated for the possibility of a pre-existing infection (e.g., [at an] access site). The dialysis procedure should also be evaluated to rule out the use of contaminated water, errors in treatment delivery, or incorrect dialyzer reprocessing.

13.2.2 Other symptoms

Other unexplained symptoms such as pain in the blood- access arm at the onset of dialysis should be evaluated by the physician, [advanced practice registered nurse or physician assistant] [and[ consideration given to the possibility that the symptom may be attributable to residual disinfectant in the new or reprocessed dialyzer or contamination of the water treatment equipment.

Suspected reactions to the residual germicide should prompt reevaluation of the rinsing procedure and tests for residual germicide (see [AAMI] 12.4.1).

CMS's interpretive guidance

Interpretive Guidance § 494.50(b)(1)

AAMI Rationale for the Development and Provisions of this Recommended Practice

A.13.2 Symptoms

Evaluation by a physician is required to determine whether symptoms might constitute an adverse reaction to the reprocessed dialyzer because symptoms during dialysis are commonly the result of other factors, such as infections not attributable to dialysis, and to hypovolemia. First-use syndrome is a symptom complex characterized by nervousness, chest pain, back pain, palpitations, pruritus, and other usually mild symptoms, occurring minutes following the initiation of dialysis with a new dialyzer. [The syndrome is defined by some authorities] to include the anaphylactoid reaction [occurring usually] immediately after the initiation of dialysis in some patients using dialyzers sterilized with ethylene oxide. In addition to first-use syndrome, serious reactions have been reported in patients taking ACE (angiotensin-converting enzyme) inhibitors and dialyzed on certain synthetic membranes. This reaction is now known to involve increased bradykinin release accompanied by suppression of bradykinin degradation.

Additional Guidance:

Physicians or non-physician practitioners (i.e., advanced practice registered nurses or physician assistants) functioning in lieu of physicians are responsible for evaluating the symptoms discussed in this regulation. Patient temperatures must be checked pre- and post-treatment, and signs of infection must be evaluated for any potential relationship to reprocessing/reuse.

One of the symptoms of germicide infusion is severe pain and burning in the patient’s vascular access. Patients may interpret pain in the vascular access site at the onset of dialysis as being related to needle insertion pain.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 174 (the full 469-page PDF) before quoting it.